1. Benefits of atomic-level processing by quasi-ALE and ALD technique. (16th May 2017) Authors: Honda, M; Katsunuma, T; Tabata, M; Tsuji, A; Oishi, T; Hisamatsu, T; Ogawa, S; Kihara, Y Journal: Journal of physics Issue: Volume 50:Number 23(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PD-013RAS mutations in circulating tumor DNA (ctDNA) and clinical outcomes of rechallenge treatments with anti-EGFR antibodies in patients with metastatic colorectal cancer (mCRC). (2nd July 2019) Authors: Sunakawa, Y; Nakamura, M; Ishizaki, M; Kataoka, M; Satake, H; Kitazono, M; Yanagisawa, H; Kawamoto, Y; Kuramochi, H; Ohori, H; Nakamura, M; Takahashi, K; Maeda, F; Komeno, C; Takeuchi, M; Fujii, M; Yoshino, T; Ichikawa, W; Tsuji, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 107PPhase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results. (25th November 2018) Authors: Kagawa, Y; Satake, H; Kato, T; Oba, K; Yasui, H; Nakamura, M; Watanabe, T; Hirata, K; Muro, K; Komatsu, Y; Yoshino, T; Yamazaki, K; Mishima, H; Kotaka, M; Tsuji, A; Kakeji, Y; Oki, E; Nagata, N; Junichi, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 483PA biomarker study to validate predictors for clinical outcome of cetuximab based chemotherapy in first-line metastatic colorectal cancer (mCRC) patients: JACCRO CC-05/06AR and FIRE-3. (23rd October 2018) Authors: Sunakawa, Y; Stintzing, S; Cao, S; Luecke, J; Thompson, D; Moran, M; Astrow, S H; Hsiang, J; Stephens, C; Zhang, W; Tsuji, A; Takahashi, T; Denda, T; Shimada, K; Kochi, M; Takeuchi, M; Fujii, M; Ichikawa, W; Heinemann, V; Lenz, H-J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1169Severity of chronic kidney disease predicts the prevalence of left atrial low-voltage areas. (19th March 2018) Authors: Matsuda, Y; Masuda, M; Asai, M; Iida, O; Okamoto, S; Ishihara, T; Nanto, K; Kanda, T; Tsujimura, T; Okuno, S; Ohashi, T; Kawai, H; Tsuji, A; Hata, Y; Mano, T Journal: Europace Issue: Volume 20(2018)Supplement 1 Page Start: i224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P-233Trifluridine/tipiracil vs regorafenib as salvage-line treatment in patients with metastatic colorectal cancer: A multicenter retrospective study. (20th June 2018) Authors: Kotaka, M; Ogata, M; Ogata, T; Hatachi, Y; Yasui, H; Kato, T; Tsuji, A; Satake, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P-243Phase II study of third-line panitumumab rechallenge in patients with metastatic wild-type KRAS colorectal cancer who achieved a clinical benefit in response to first-line panitumumab plus chemotherapy. (20th June 2018) Authors: Tsuji, A; Nakamura, M; Watanabe, T; Manaka, D; Matsuoka, H; Kataoka, M; Takeuchi, M; Ichikawa, W; Fujii, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P-244Dose finding phase Ib study of triplet plus cetuximab for patients with wild-type RAS gene metastatic colorectal cancer (TRICETSU study). (20th June 2018) Authors: Satake, H; Kotake, T; Okita, Y; Hatachi, Y; Yasui, H; Kotaka, M; Kato, T; Tsuji, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P-294Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress. (20th June 2018) Authors: Kato, T; Satake, H; Oba, K; Kagawa, Y; Yasui, H; Nakamura, M; Watanabe, T; Matsumoto, T; Hirata, K; Muro, K; Komatsu, Y; Yoshino, T; Yamazaki, K; Mishima, H; Kotaka, M; Tsuji, A; Kakeji, Y; Oki, E; Nagata, N; Sakamoto, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P-233Trifluridine/tipiracil vs regorafenib as salvage-line treatment in patients with metastatic colorectal cancer: A multicenter retrospective study. (20th June 2018) Authors: Kotaka, M; Ogata, M; Ogata, T; Hatachi, Y; Yasui, H; Kato, T; Tsuji, A; Satake, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗